By Counterforce Health Team in Zanzalintinib (XL092) [investigational] —

Work With Your Doctor to Get Zanzalintinib (XL092) Covered by Blue Cross Blue Shield in Washington: Complete Appeals Guide

Answer Box: Your Path to Coverage

Getting Zanzalintinib (XL092) covered by Blue Cross Blue Shield in Washington requires close collaboration with your oncologist. This investigational multi-target TKI is typically denied as "experimental," but appeals succeed when you demonstrate medical necessity through Exelixis's compassionate use program, document failed standard therapies, and leverage Washington's strong external review process. Start today by scheduling a visit to discuss your treatment timeline and gather prior therapy documentation.

Table of Contents

  1. Set Your Goal: Understanding What Approval Requires
  2. Visit Preparation: Building Your Clinical Story
  3. Evidence Kit: Assembling Your Documentation
  4. Medical Necessity Letter Structure
  5. Peer-to-Peer Review Support
  6. After-Visit Documentation Strategy
  7. Respectful Persistence: Following Up Effectively
  8. Appeals Playbook for Washington
  9. When to Escalate to External Review
  10. FAQ

Set Your Goal: Understanding What Approval Requires

Blue Cross Blue Shield typically denies Zanzalintinib (XL092) because it's investigational—not yet FDA-approved for any indication. However, coverage is possible through Exelixis's compassionate use program combined with a strong medical necessity appeal.

Coverage Requirements Checklist

Requirement What It Means Your Role
Compassionate Use Approval Exelixis must authorize access Work with oncologist to apply
Medical Necessity Documentation Failed/intolerant to standard therapies Compile treatment history
Clinical Rationale Why XL092 is appropriate for your case Help gather supporting evidence
Prior Authorization BCBS formal review process Support your doctor's submission

Your partnership with your oncologist is crucial because only physicians can apply for compassionate use and submit prior authorization requests. Your job is to provide complete information and advocate effectively.

Note: Counterforce Health helps patients and clinicians turn insurance denials into targeted appeals by analyzing denial letters and crafting evidence-backed rebuttals. Their platform specializes in complex cases like investigational drug coverage.

Visit Preparation: Building Your Clinical Story

Before meeting with your oncologist, organize your medical journey to help them build the strongest possible case.

Your Treatment Timeline

Document these key elements:

Diagnosis Details:

  • Exact cancer type and stage
  • Date of diagnosis
  • Molecular/genetic testing results
  • ICD-10 codes (ask for copies)

Prior Therapies:

  • List every treatment you've tried
  • Dates of treatment
  • Reasons for stopping (progression, side effects, intolerance)
  • Response duration for each therapy

Current Status:

  • Performance status and symptoms
  • Recent scans or lab results
  • Quality of life impact
  • Treatment goals

Symptom and Functional Impact Notes

Keep a brief log of:

  • Daily symptoms and severity (1-10 scale)
  • Activities you can no longer do
  • How current treatments affect your daily life
  • Specific side effects from previous therapies

This information helps your doctor articulate why standard options are insufficient and why XL092's investigational status is justified.

Evidence Kit: Assembling Your Documentation

Work with your care team to gather these essential documents:

Medical Records

  • Complete pathology reports
  • Imaging studies (CT, MRI, PET scans)
  • Lab results showing disease markers
  • Previous treatment summaries
  • Consultation notes from specialists

Insurance Documentation

  • Current BCBS policy details
  • Formulary information
  • Previous prior authorization attempts
  • Any denial letters received

Supporting Literature

Your oncologist will identify relevant studies, but you can help by researching:

Tip: Request copies of all records in advance. Many practices need 5-7 business days to compile comprehensive documentation.

Medical Necessity Letter Structure

Your oncologist will write the formal medical necessity letter, but understanding the structure helps you provide relevant information during your visit.

Essential Components

1. Clinical Problem Statement

  • Your specific diagnosis with staging
  • Why this represents a serious/life-threatening condition
  • Current disease status and prognosis

2. Prior Treatment Documentation

  • Chronological list of therapies tried
  • Specific reasons each failed or caused intolerance
  • Duration of response where applicable
  • Supporting lab values or imaging

3. Clinical Rationale for XL092

  • Mechanism of action relevant to your cancer
  • Published evidence supporting multi-target TKI approach
  • Why approved alternatives are inappropriate

4. Compassionate Use Authorization

  • Reference to Exelixis approval letter
  • IRB and regulatory compliance documentation
  • Treatment plan and monitoring schedule

5. Guideline Citations Your doctor should reference:

  • NCCN guidelines for your cancer type
  • Published studies on multi-target TKIs
  • FDA breakthrough therapy designations for similar agents
  • Relevant case reports or series

Peer-to-Peer Review Support

When BCBS requests a peer-to-peer review, your preparation helps your oncologist present the strongest case.

How You Can Help

Provide Availability Windows:

  • Give your doctor multiple time slots when you're available
  • Be prepared for short-notice scheduling
  • Offer to join the call if permitted

Create a Case Summary: Prepare a one-page summary including:

  • Your cancer journey in chronological order
  • Failed treatments and why they didn't work
  • Current symptoms and functional status
  • Why delay in treatment is risky

Key Talking Points for Your Doctor

Help your oncologist prepare these arguments:

  • "Standard therapies have failed due to [specific reasons]"
  • "XL092's multi-target mechanism addresses resistance pathways"
  • "Exelixis compassionate use approval demonstrates clinical appropriateness"
  • "Delay risks disease progression and loss of treatment window"
  • "Published data supports multi-target TKI approach in this setting"

After-Visit Documentation Strategy

Maximize the value of each appointment by documenting key information.

What to Save

  • Visit summary with treatment plan
  • Updated medication lists
  • New test results or imaging reports
  • Changes to your condition or symptoms
  • Provider recommendations and rationale

Portal Communication Tips

When messaging through your patient portal:

Be Specific:

  • "Following up on our discussion about XL092 prior authorization"
  • "Attaching insurance denial letter from [date]"
  • "Question about next steps in appeals process"

Include Context:

  • Reference previous conversations
  • Attach relevant documents
  • Provide timeline for urgent requests

Respectful Persistence: Following Up Effectively

Maintaining momentum without overwhelming your care team requires strategic communication.

Follow-Up Cadence

Week 1-2: Initial submission and acknowledgment Week 3-4: Status check and additional documentation Week 5+: Escalation if no response

How to Escalate Politely

First Level: Direct message to your oncologist Second Level: Call the nurse coordinator Third Level: Request appointment with practice manager Fourth Level: Contact Counterforce Health for appeals assistance

Communication Scripts

Status Check: "Hi Dr. [Name], I wanted to follow up on the XL092 prior authorization we discussed. Do you need any additional information from me to move this forward?"

Offering Help: "I'm happy to contact insurance directly or gather any additional documentation that might be helpful for the appeal."

Gentle Urgency: "Given my current disease status, I'm concerned about treatment delays. What can we do to expedite this process?"

Appeals Playbook for Washington

Washington state provides strong consumer protections for insurance appeals, including binding external review.

Internal Appeals Process

Level Timeline How to Submit Required Documents
First Internal 15-30 days Provider portal or fax Medical necessity letter, clinical notes
Second Internal 15-30 days Same as first level Additional evidence, peer review notes

Required Documentation

  • Complete medical records
  • Exelixis compassionate use approval
  • Prior therapy failure documentation
  • Published literature supporting treatment
  • Provider attestation to medical necessity
Important: Keep copies of all submissions and request confirmation of receipt.

When to Escalate to External Review

If internal appeals fail, Washington's external review process provides a final opportunity for coverage.

External Review Timeline

Standard Review: 15-20 days for decision Expedited Review: 72 hours for urgent cases Filing Deadline: 180 days from final internal denial

How to Request External Review

  1. File Request: Submit to your BCBS plan or directly to Washington Insurance Commissioner
  2. Provide Documentation: All medical records and supporting evidence
  3. IRO Assignment: Independent review organization assigned automatically
  4. Decision: Binding on BCBS if approved

Success Factors

  • Complete medical documentation
  • Clear demonstration of medical necessity
  • Evidence of failed standard therapies
  • Published support for investigational use

Contact the Washington Insurance Commissioner at 1-800-562-6900 for assistance with the external review process.

FAQ

How long does BCBS prior authorization take in Washington? Standard prior authorization decisions are typically made within 15 business days. Expedited reviews for urgent cases can be completed in 72 hours.

What if Zanzalintinib is not on BCBS formulary? Non-formulary drugs require formulary exception requests with medical necessity documentation. Your doctor must demonstrate why formulary alternatives are inappropriate.

Can I request an expedited appeal? Yes, if delay in treatment could seriously jeopardize your health. Provide documentation of urgency from your oncologist.

Does step therapy apply if I've failed treatments outside Washington? Treatment failures from any location count toward step therapy requirements. Provide complete documentation from all treating physicians.

What happens if external review upholds the denial? External review decisions are binding, but you can still explore other options like manufacturer assistance programs or clinical trials.

How much does Zanzalintinib cost without insurance? As an investigational drug, XL092 has no established price. Costs through compassionate use programs are typically covered by the manufacturer.

Can I appeal multiple times? You get one internal appeal (sometimes two levels) and one external review per denial. New medical information can support additional requests.

What if my BCBS plan is self-funded through my employer? Self-funded plans follow different rules but often use similar appeal processes. Contact your HR department and consider Department of Labor assistance for ERISA plans.

Counterforce Health specializes in turning complex insurance denials into successful appeals by analyzing denial letters, plan policies, and clinical evidence to craft targeted rebuttals. Their platform helps patients and clinicians navigate the intricate world of prior authorizations and appeals, particularly for challenging cases involving investigational therapies and specialty medications.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance plan for specific coverage decisions. Treatment decisions should be made in consultation with qualified medical professionals.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.